These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 22615675)

  • 1. A systematic review on pharmacokinetic changes in critically ill patients: role of extracorporeal membrane oxygenation.
    Mousavi S; Levcovich B; Mojtahedzadeh M
    Daru; 2011; 19(5):312-21. PubMed ID: 22615675
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.
    Sherwin J; Heath T; Watt K
    Clin Ther; 2016 Sep; 38(9):1976-94. PubMed ID: 27553752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population Pharmacokinetics and Dosing Optimization of Piperacillin-Tazobactam in Critically Ill Patients on Extracorporeal Membrane Oxygenation and the Influence of Concomitant Renal Replacement Therapy.
    Hahn J; Min KL; Kang S; Yang S; Park MS; Wi J; Chang MJ
    Microbiol Spectr; 2021 Dec; 9(3):e0063321. PubMed ID: 34937189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic changes of antibiotic, antiviral, antituberculosis and antifungal agents during extracorporeal membrane oxygenation in critically ill adult patients.
    Hahn J; Choi JH; Chang MJ
    J Clin Pharm Ther; 2017 Dec; 42(6):661-671. PubMed ID: 28948652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Population Pharmacokinetics and Dosing Simulations of Ceftriaxone in Critically Ill Patients Receiving Extracorporeal Membrane Oxygenation (An ASAP ECMO Study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Cho YJ; Corley A; Gilder E; Kim HS; Lim SY; McGuinness S; Parke R; Reynolds C; Rudham S; Wallis SC; Welch SA; Fraser JF; Shekar K; Roberts JA;
    Clin Pharmacokinet; 2022 Jun; 61(6):847-856. PubMed ID: 35253107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation.
    Shekar K; Fraser JF; Smith MT; Roberts JA
    J Crit Care; 2012 Dec; 27(6):741.e9-18. PubMed ID: 22520488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotic dosing during extracorporeal membrane oxygenation: does the system matter?
    Abdul-Aziz MH; Roberts JA
    Curr Opin Anaesthesiol; 2020 Feb; 33(1):71-82. PubMed ID: 31764007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Narrative Review of the Impact of Extracorporeal Membrane Oxygenation on the Pharmacokinetics and Pharmacodynamics of Critical Care Therapies.
    Patel JS; Kooda K; Igneri LA
    Ann Pharmacother; 2023 Jun; 57(6):706-726. PubMed ID: 36250355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Altered Drug Pharmacokinetics in Critically Ill Adults Receiving Extracorporeal Membrane Oxygenation.
    Ha MA; Sieg AC
    Pharmacotherapy; 2017 Feb; 37(2):221-235. PubMed ID: 27931091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics Alterations in Critically Ill Pediatric Patients on Extracorporeal Membrane Oxygenation: A Systematic Review.
    Sutiman N; Koh JC; Watt K; Hornik C; Murphy B; Chan YH; Lee JH
    Front Pediatr; 2020; 8():260. PubMed ID: 32670992
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical pharmacokinetics of anti-infective drugs in extracorporeal membrane oxygenation].
    Reimer A; Vogl H; Schmid S; Gfrörer S; Bürle M; Hoffmann M; Geldner G
    Anaesthesist; 2019 Dec; 68(12):821-826. PubMed ID: 31740986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life-threatening severe infections during support with or without extracorporeal membrane oxygenation in an intensive care unit.
    Jaruratanasirikul S; Boonpeng A; Nawakitrangsan M; Samaeng M
    Pharmacotherapy; 2021 Jul; 41(7):572-597. PubMed ID: 34080708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Disposition and Pharmacotherapy in Neonatal ECMO: From Fragmented Data to Integrated Knowledge.
    Raffaeli G; Pokorna P; Allegaert K; Mosca F; Cavallaro G; Wildschut ED; Tibboel D
    Front Pediatr; 2019; 7():360. PubMed ID: 31552205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software.
    Roberts JA; Bellomo R; Cotta MO; Koch BCP; Lyster H; Ostermann M; Roger C; Shekar K; Watt K; Abdul-Aziz MH
    Intensive Care Med; 2022 Oct; 48(10):1338-1351. PubMed ID: 35997793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imipenem Population Pharmacokinetics: Therapeutic Drug Monitoring Data Collected in Critically Ill Patients with or without Extracorporeal Membrane Oxygenation.
    Chen W; Zhang D; Lian W; Wang X; Du W; Zhang Z; Guo D; Zhang X; Zhan Q; Li P
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32253220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Population pharmacokinetics of ciprofloxacin in critically ill patients receiving extracorporeal membrane oxygenation (an ASAP ECMO study).
    Cheng V; Abdul-Aziz MH; Burrows F; Buscher H; Corley A; Diehl A; Levkovich BJ; Pellegrino V; Reynolds C; Rudham S; Wallis SC; Welch SA; Roberts JA; Shekar K; Fraser JF;
    Anaesth Crit Care Pain Med; 2022 Jun; 41(3):101080. PubMed ID: 35472580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of extracorporeal membrane oxygenation on antifungal pharmacokinetics: A systematic review.
    Jendoubi A; Pressiat C; De Roux Q; Hulin A; Ghaleh B; Tissier R; Kohlhauer M; Mongardon N
    Int J Antimicrob Agents; 2024 Feb; 63(2):107078. PubMed ID: 38161046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of oseltamivir and oseltamivir carboxylate in critically ill patients receiving continuous venovenous hemodialysis and/or extracorporeal membrane oxygenation.
    Eyler RF; Heung M; Pleva M; Sowinski KM; Park PK; Napolitano LM; Mueller BA
    Pharmacotherapy; 2012 Dec; 32(12):1061-9. PubMed ID: 23208833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of caspofungin and voriconazole in critically ill patients during extracorporeal membrane oxygenation.
    Spriet I; Annaert P; Meersseman P; Hermans G; Meersseman W; Verbesselt R; Willems L
    J Antimicrob Chemother; 2009 Apr; 63(4):767-70. PubMed ID: 19218271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental research approach to describing the pharmacokinetics of ciprofloxacin during extracorporeal membrane oxygenation.
    Sinnah F; Shekar K; Abdul-Aziz MH; Buscher H; Diab SD; Fisquet S; Fung YL; McDonald CI; Reynolds C; Rudham S; Wallis SC; Welch S; Xie J; Fraser JF; Roberts JA;
    Crit Care Resusc; 2017 Oct; 19(Suppl 1):8-14. PubMed ID: 29084496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.